<DOC>
	<DOCNO>NCT01490229</DOCNO>
	<brief_summary>Pharmacologic alternative statin-intolerant patient include ezetimibe nutraceuticals ( i.e . compound derived food cholesterol lower action ) . The investigator compare efficacy tolerability ezetimibe versus nutraceutical-based protocol statin-intolerant patient treat percutaneous coronary intervention .</brief_summary>
	<brief_title>Ezetimibe Versus Nutraceuticals Statin-intolerant Patients</brief_title>
	<detailed_description>Background Treatment statins class I indication percutaneous coronary intervention ( PCI ) , often discontinue patient due side effect . Pharmacologic alternative show useful PCI include ezetimibe nutraceuticals ( i.e . compound derived food cholesterol lower action ) . It remain unknown , however , two therapeutic approach effective PCI . Purpose The primary objective study compare efficacy tolerability ezetimibe versus nutraceutical-based protocol statin-intolerant patient treat percutaneous coronary intervention .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Angiographicallyproven coronary artery disease Recent ( &lt; 12 month ) percutaneous coronary intervention Class I indication receive statin treatment Previous ( &lt; 12 month ) withdraw statin due side effect Unwilling receive treatment alternative statin Able understand willing sign inform consent form â€¢ Women child bear potential patient must demonstrate negative pregnancy test perform within 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>nutraceuticals</keyword>
	<keyword>statin</keyword>
</DOC>